We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+7.56%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$40.8B
AUM Growth
+$3.42B
(+9.2%)
Cap. Flow
+$1.07B
Cap. Flow
% of AUM
2.63%
Top 10 Holdings %
Top 10 Hldgs %
25.28%
Holding
2,151
New
303
Increased
1,108
Reduced
653
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$197M |
| 2 |
Walmart Inc
WMT
|
+$193M |
| 3 |
NextEra Energy
NEE
|
+$177M |
| 4 |
Apple
AAPL
|
+$129M |
| 5 |
UnitedHealth
UNH
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$230M |
| 2 |
Sysco
SYY
|
+$164M |
| 3 |
Synopsys
SNPS
|
+$81.2M |
| 4 |
C.H. Robinson
CHRW
|
+$53.8M |
| 5 |
United Bankshares
UBSI
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.01% |
| 2 | Consumer Staples | 11.62% |
| 3 | Industrials | 10.88% |
| 4 | Consumer Discretionary | 9.53% |
| 5 | Healthcare | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Lantronix
LTRX
$236M
| $51.2K | ﹤0.01% |
12,426
+641
| +5% | +$2.42K |
|
1977
MacroGenics
MGNX
$235M
| $50.4K | ﹤0.01% |
15,321
+3,303
| +27% | +$12.9K |
|
|
PHLT
1978
DELISTED
Performant Healthcare Inc
PHLT
| $50K | ﹤0.01% |
+13,364
| New | +$45.7K |
|
|
SAVE
1979
DELISTED
Spirit Airlines, Inc.
SAVE
| $49.8K | ﹤0.01% |
20,742
+6,037
| +41% | +$16.6K |
|
1980
MeiraGTx Holdings
MGTX
$1.09B
| $49.6K | ﹤0.01% |
+11,904
| New | +$51.5K |
|
1981
8x8 Inc
EGHT
$247M
| $49.3K | ﹤0.01% |
24,154
+7,622
| +46% | +$16.8K |
|
1982
Talkspace
TALK
$873M
| $48.6K | ﹤0.01% |
+23,230
| New | +$45.3K |
|
1983
ADC Therapeutics
ADCT
$146M
| $48.4K | ﹤0.01% |
+15,366
| New | +$48.5K |
|
1984
Ocugen
OCGN
$410M
| $48K | ﹤0.01% |
+48,351
| New | +$66.4K |
|
|
SFIX
1985
Stitch Fix
SFIX
$478M
| $47.9K | ﹤0.01% |
16,983
+4,998
| +42% | +$19.5K |
|
1986
Nautilus Biotechnolgy
NAUT
$215M
| $47.4K | ﹤0.01% |
16,616
+2,122
| +15% | +$5.49K |
|
1987
AbCellera Biologics
ABCL
$1.62B
| $45.3K | ﹤0.01% |
17,412
-740
| -4% | -$2.05K |
|
1988
Definitive Healthcare
DH
$72.1M
| $45K | ﹤0.01% |
+10,075
| New | +$47.3K |
|
1989
Ring Energy
REI
$322M
| $44.8K | ﹤0.01% |
28,003
+11,937
| +74% | +$21.3K |
|
1990
Heron Therapeutics
HRTX
$86.3M
| $44.1K | ﹤0.01% |
22,183
+8,314
| +60% | +$19.9K |
|
1991
Nektar Therapeutics
NKTR
$2.39B
| $43.9K | ﹤0.01% |
+2,249
| New | +$42.9K |
|
|
AUTL
1992
Autolus Therapeutics
AUTL
$386M
| $42.8K | ﹤0.01% |
11,796
-517
| -4% | -$2.06K |
|
1993
X4 Pharmaceuticals
XFOR
$363M
| $42.5K | ﹤0.01% |
2,117
+1,558
| +279% | +$32.5K |
|
|
ONL
1994
Orion Office REIT
ONL
$148M
| $42.4K | ﹤0.01% |
+10,609
| New | +$41.6K |
|
1995
Omeros
OMER
$709M
| $42K | ﹤0.01% |
+10,569
| New | +$45.1K |
|
|
EB
1996
DELISTED
Eventbrite
EB
| $41.5K | ﹤0.01% |
15,210
+4,848
| +47% | +$18.4K |
|
1997
Caribou Biosciences
CRBU
$156M
| $40.9K | ﹤0.01% |
20,886
+4,345
| +26% | +$8.9K |
|
1998
BARK
BARK
$74.8M
| $40.8K | ﹤0.01% |
1,252
+358
| +40% | +$11.6K |
|
1999
Codexis
CDXS
$135M
| $40.7K | ﹤0.01% |
+13,199
| New | +$40.8K |
|
|
MRSN
2000
DELISTED
Mersana Therapeutics
MRSN
| $40.5K | ﹤0.01% |
857
+263
| +44% | +$11.6K |
|
Similar funds
ProShare Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, ProShare Advisors held 2,151 positions worth $40.8B, up 9.2% from $37.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
ProShare Advisors's Q3 2024 filing shows 303 new, 1,108 increased, 653 reduced and 86 closed positions. Its largest new stake was NexPoint Residential Trust: 319,514 shares worth $14.1M. The largest sale was Qualcomm, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Consumer Staples and Industrials.
- ProShare Advisors's largest Q3 2024 buy was NexPoint Residential Trust: 319,514 shares worth $14.1M.
- ProShare Advisors added most to West Pharmaceutical in Q3 2024, an estimated $197M increase.
- ProShare Advisors's biggest Q3 2024 reduction was Qualcomm, cutting an estimated $230M.
- ProShare Advisors fully exited Atrion Corp in Q3 2024, selling an estimated $8.02M.
- ProShare Advisors's ten largest holdings make up 25% of its $40.8B portfolio in Q3 2024.
- ProShare Advisors opened 303 new positions and closed 86 in Q3 2024.
- ProShare Advisors's portfolio value rose 9.2% quarter-over-quarter to $40.8B.
Based on ProShare Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.